- Home
- ONTF vs CYBN Comparison
ONTF vs CYBN Comparison
Compare ONTF & CYBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONTF
- CYBN
- Stock Information
- Founded
- ONTF 1998
- CYBN 2019
- Country
- ONTF United States
- CYBN Canada
- Employees
- ONTF N/A
- CYBN N/A
- Industry
- ONTF Computer Software: Prepackaged Software
- CYBN Pharmaceuticals and Biotechnology
- Sector
- ONTF Technology
- CYBN Health Care
- Exchange
- ONTF Nasdaq
- CYBN Nasdaq
- Market Cap
- ONTF 273.3M
- CYBN 229.8M
- IPO Year
- ONTF 2021
- CYBN N/A
- Fundamental
- Price
- ONTF $6.44
- CYBN $9.80
- Analyst Decision
- ONTF Hold
- CYBN Strong Buy
- Analyst Count
- ONTF 3
- CYBN 3
- Target Price
- ONTF $8.00
- CYBN $138.00
- AVG Volume (30 Days)
- ONTF 108.9K
- CYBN 605.5K
- Earning Date
- ONTF 11-07-2024
- CYBN 11-13-2024
- Dividend Yield
- ONTF N/A
- CYBN N/A
- EPS Growth
- ONTF N/A
- CYBN N/A
- EPS
- ONTF N/A
- CYBN N/A
- Revenue
- ONTF $150,738,000.00
- CYBN N/A
- Revenue This Year
- ONTF N/A
- CYBN N/A
- Revenue Next Year
- ONTF N/A
- CYBN N/A
- P/E Ratio
- ONTF N/A
- CYBN N/A
- Revenue Growth
- ONTF N/A
- CYBN N/A
- 52 Week Low
- ONTF $5.37
- CYBN $6.50
- 52 Week High
- ONTF $8.35
- CYBN $21.66
- Technical
- Relative Strength Index (RSI)
- ONTF 53.34
- CYBN 44.53
- Support Level
- ONTF $6.16
- CYBN $10.36
- Resistance Level
- ONTF $6.75
- CYBN $13.88
- Average True Range (ATR)
- ONTF 0.24
- CYBN 1.38
- MACD
- ONTF -0.01
- CYBN -0.14
- Stochastic Oscillator
- ONTF 62.87
- CYBN 13.54
About ONTF ON24 Inc.
ON24 Inc provides a cloud-based digital experience platform that enables businesses to convert customer engagement into revenue through interactive webinar experiences, virtual event experiences, and multimedia content experiences. The company derives revenue from subscription agreements with customers for accessing the platform and related services. Geographically, it derives a majority of revenue from the United States.
About CYBN Cybin Inc.
Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The company is focused on advancing psychedelic-based therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions.